Skip to content

Effect and adherence of home fecal occult blood test screening in colorectal cancer patients' first degree relatives

Effect and adherence of home fecal occult blood test screening in colorectal cancer patients' first degree relatives

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039012
Enrollment
Unknown
Registered
2020-10-13
Start date
2020-10-30
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Control group:health education
Intervention group:health education combined with home fecal occulted blood test

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1) Subjects who sign the informed consent and are willing to complete the study according to the study protocol; 2) Aged 40-74 years; 3) First-degree relatives of colorectal cancer patients who were treated in Fudan University Shanghai Cancer Center, including parents, siblings and children.

Exclusion criteria

Exclusion criteria: 1) Refuse to upload the results of fecal occult blood test; 2) History of colorectal cancer or surgery history of digestive system tumors; 3) History of Systemic diseases, such as severe cardiopulmonary insufficiency, liver and kidney dysfunction, et al; 4) History of familial adenomatous polyposis or Lynch syndrome; 5) History of colonoscopy detection within 5 years; 6) Fecal bleeding, symptom of upper gastrointestinal bleeding, and diagnosed as ulcerative colitis; 7) The researcher considers the subject inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Detection rate of colorectal cancer and precancerous lesions;

Secondary

MeasureTime frame
Stage of colorectal cancer;Cumulative participation rate of colonoscopy detection;Cumulative participation rate of colonoscopy detection;screening utilization rate;Cost Effectiveness Ratio;Incremental Cost Effectiveness Ratio;

Countries

China

Contacts

Public ContactYing Zheng

Fudan University Shanghai Cancer Center

zhengying@fudan.edu.cn+86 18121299522

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026